Detail Information
Publications
Parental and other factors associated with hydroxyurea use for pediatric sickle cell diseaseSuzette O Oyeku
Department of Pediatrics, Division of General Pediatrics, Children s Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10467, USA
Pediatr Blood Cancer 60:653-8. 2013..Hydroxyurea (HU) is highly effective treatment for sickle cell disease (SCD). While pediatric use of HU is accepted clinical practice, barriers to use may impede its potential benefit...
Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategiesSuzette O Oyeku
Division of General Pediatrics, The Children s Hospital at Montefiore, Bronx, New York, USA
J Natl Med Assoc 102:676-82. 2010..We assessed clinicians' knowledge, confidence, and practices regarding hemoglobinopathy newborn screening, and the effect of mailed educational materials vs interactive seminar on knowledge and confidence...
